BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26260992)

  • 1. Differential crosstalk between the AMPK and PI3K/Akt pathways in breast cancer cells of differing genotypes: Leptin inhibits the effectiveness of AMPK activation.
    El-Masry OS; Al-Sakkaf K; Brown BL; Dobson PR
    Oncol Rep; 2015 Oct; 34(4):1675-80. PubMed ID: 26260992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine 5'-monophosphate-activated protein kinase regulates IL-10-mediated anti-inflammatory signaling pathways in macrophages.
    Zhu YP; Brown JR; Sag D; Zhang L; Suttles J
    J Immunol; 2015 Jan; 194(2):584-94. PubMed ID: 25512602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docosahexaenoic Acid Induces Cell Death in Human Non-Small Cell Lung Cancer Cells by Repressing mTOR via AMPK Activation and PI3K/Akt Inhibition.
    Kim N; Jeong S; Jing K; Shin S; Kim S; Heo JY; Kweon GR; Park SK; Wu T; Park JI; Lim K
    Biomed Res Int; 2015; 2015():239764. PubMed ID: 26339598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
    Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
    Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ionizing radiation regulates the expression of AMP-activated protein kinase (AMPK) in epithelial cancer cells: modulation of cellular signals regulating cell cycle and survival.
    Sanli T; Storozhuk Y; Linher-Melville K; Bristow RG; Laderout K; Viollet B; Wright J; Singh G; Tsakiridis T
    Radiother Oncol; 2012 Mar; 102(3):459-65. PubMed ID: 22225791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.
    Scherbakov AM; Sorokin DV; Tatarskiy VV; Prokhorov NS; Semina SE; Berstein LM; Krasil'nikov MA
    IUBMB Life; 2016 Apr; 68(4):281-92. PubMed ID: 26892736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central leptin action improves skeletal muscle AKT, AMPK, and PGC1 alpha activation by hypothalamic PI3K-dependent mechanism.
    Roman EA; Reis D; Romanatto T; Maimoni D; Ferreira EA; Santos GA; Torsoni AS; Velloso LA; Torsoni MA
    Mol Cell Endocrinol; 2010 Jan; 314(1):62-9. PubMed ID: 19698760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the AKT/mTOR and erbB pathways by gefitinib, perifosine and analogs of gonadotropin-releasing hormone I and II to overcome tamoxifen resistance in breast cancer cells.
    Block M; Gründker C; Fister S; Kubin J; Wilkens L; Mueller MD; Hemmerlein B; Emons G; Günthert AR
    Int J Oncol; 2012 Nov; 41(5):1845-54. PubMed ID: 22922893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin-stimulated endothelial nitric-oxide synthase via an adenosine 5'-monophosphate-activated protein kinase/Akt signaling pathway is attenuated by interaction with C-reactive protein.
    Procopio C; Andreozzi F; Laratta E; Cassese A; Beguinot F; Arturi F; Hribal ML; Perticone F; Sesti G
    Endocrinology; 2009 Aug; 150(8):3584-93. PubMed ID: 19359389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.
    Chen X; Zhao M; Hao M; Sun X; Wang J; Mao Y; Zu L; Liu J; Shen Y; Wang J; Shen K
    Mol Cancer Res; 2013 Oct; 11(10):1269-78. PubMed ID: 23814023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
    Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
    J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleurotus nebrodensis polysaccharide(PN50G) evokes A549 cell apoptosis by the ROS/AMPK/PI3K/AKT/mTOR pathway to suppress tumor growth.
    Cui H; Wu S; Shang Y; Li Z; Chen M; Li F; Wang C
    Food Funct; 2016 Mar; 7(3):1616-27. PubMed ID: 26918909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells.
    Sengupta S; Schiff R; Katzenellenbogen BS
    Breast Cancer Res Treat; 2009 Sep; 117(2):243-51. PubMed ID: 18807177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol suppresses UV-Induced MMP-1 expression through AMPK-mediated mTOR inhibition as a downstream of the PKA-LKB1 pathway.
    Shin DJ; Kim JE; Lim TG; Jeong EH; Park G; Kang NJ; Park JS; Yeom MH; Oh DK; Bode AM; Dong Z; Lee HJ; Lee KW
    J Cell Biochem; 2014 Oct; 115(10):1702-11. PubMed ID: 24821673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin exerts proliferative and anti-apoptotic effects on goose granulosa cells through the PI3K/Akt/mTOR signaling pathway.
    Wen R; Hu S; Xiao Q; Han C; Gan C; Gou H; Liu H; Li L; Xu H; He H; Wang J
    J Steroid Biochem Mol Biol; 2015 May; 149():70-9. PubMed ID: 25576904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Han S; Khuri FR; Roman J
    Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
    PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
    Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
    Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cervical cancer cell growth through activation of upstream kinases of AMP-activated protein kinase.
    Yu SY; Chan DW; Liu VW; Ngan HY
    Tumour Biol; 2009; 30(2):80-5. PubMed ID: 19407487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction pathways in FSH regulation of rat Sertoli cell proliferation.
    Riera MF; Regueira M; Galardo MN; Pellizzari EH; Meroni SB; Cigorraga SB
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E914-23. PubMed ID: 22275758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.